[Prospective study of newborn infants born to mothers infected with human immunodeficiency virus]. 1989

J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
Departamento de Pediatría, Hospital Materno-Infantil, Nuestra Señora de Aránzazu, San Sebastián.

Perinatal transmission of Human immunodeficiency virus (HIV) from mother to child is at the present time the most important cause of AIDS in children. Since August 1985 we have observed 24 babies with anti-HIV antibodies born to HIV-infected mothers. Their present status is: 6 have symptomatic infection, 6 undetermined infection, 10 had became seronegative and 2 were lost for follow-up. Our results suggest that the risk of infection for the baby is high and the onset of symptoms relatively early. Follow-up studies in babies born to HIV-infected mothers are needed in order to classify the true risk of infection in them and the natural history of the disease.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
February 1998, The Journal of pediatrics,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
June 2006, Virology journal,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
February 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
May 1992, The Pediatric infectious disease journal,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
March 1994, The Journal of perinatal & neonatal nursing,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
January 2004, The Central African journal of medicine,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
January 1997, The Pediatric infectious disease journal,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
October 1992, The Pediatric infectious disease journal,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
March 1993, The Pediatric infectious disease journal,
J Echeverría Lecuona, and M Oliveros Vela, and G Cilla Eguiluz, and E Cuadrado del Barrio, and Y Albisu Andrade
April 1998, The Journal of infectious diseases,
Copied contents to your clipboard!